NCT07236723Not yet recruiting
Vitamin D, Nerve Growth Factor and Nerve Conduction Studies in Adult Male Type 2 Diabetic Neuropathy Patients
Source: ClinicalTrials.gov · Last updated 19 Nov 2025
Brief summary (registry, in English)
study the relationship of vitamin d with nerve growth factor level and nerve conduction studies in adult male type 2 diabetic neuropathy patients
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 57 (estimated)
- First submitted
- 15 Nov 2025
- Start date
- Dec 2025
- Primary completion date
- Feb 2026
- Lead sponsor
- Aswan University
- NCT number
- NCT07236723
What you commit to
- Study type: Observational
- Planned participants: 57
- From Dec 2025 to the primary completion date, Feb 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Cardiac patients.
- Patients who have transient ischemic attack or stroke.
- Patients with inflammatory rheumatic diseases.
- Patients with malignant diseases.
- Renal impairment with renal replacement therapy.
- Liver diseases.
Other
- Hyperparathyroidism.
- Hypothyroidism.
- Patients on vitamin D supplementation.
- Patients on vitamin B12 supplementation.
Who the study is looking for
- Adult male patients 40 -65 years' old who have type 2 diabetes mellitus on oral hypoglycemic , non-diabetic healthy subjects of matched age and type 2male diabetic neuropathy patients of matched age .
Age in the registry: 40 years to 60 years · Sex: Male · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Aswan University Hospital Coordinator of this site? Confirm its status | Aswān | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.